Found 334 matching trials
Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors PHASE2 The purpose of this study is to evaluate the efficacy and safety of recombi...
Show More Location
307 Hospital of PLA
Learn More & Join Trial
STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa PHASE2 RATIONALE: STI571 may interfere with the growth of cancer cells and may be ...
Show More Location
Novartis Pharmaceuticals Corporation
Learn More & Join Trial
Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer PHASE3 RATIONALE: Medroxyprogesterone may help shrink or slow the growth of kidney...
Show More Location
Multiple Locations
Learn More & Join Trial
Boceprevir Treatment in Liver Pre-transplant HCV Patients PHASE3 End-stage liver disease due to hepatitis C virus (HCV) is the most common i...
Show More Location
123, Ta Pei Road, Niao Sung Hsiang
Learn More & Join Trial
Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis PHASE3 The PERCY Quattro trial has been designed to evaluate the survival benefit ...
Show More Location
Centre Leon Berard
Learn More & Join Trial
DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC PHASE2 RATIONALE: Vaccines made from a patient's dendritic cells and tumor cells m...
Show More Location
Norris Cotton Cancer Center at Dartmouth - Hitchcock Medical Center
Learn More & Join Trial
Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection PHASE3 Hepatitis C virus (HCV) infection is a leading cause of death and illness i...
Show More Learn More & Join Trial
Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype PHASE3 The purpose of this study is to evaluate if a 12-week total regimen of tela...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B PHASE3 Current clinical practices has shown promising prospects of the therapy str...
Show More Location
Beijing Ditan Hospital, Capital Medical University
Learn More & Join Trial
Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia PHASE2 RATIONALE: Interferon alfa may interfere with the growth of cancer cells. I...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial